You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 145 No. 5, May 1985 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CLINICAL OBSERVATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (22)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Acute Oxalate Nephropathy After Massive Ascorbic Acid Administration

John M. Lawton, MD; Lars T. Conway, MD; John T. Crosson, MD; Charles L. Smith, MD; Paul A. Abraham, MD

Arch Intern Med. 1985;145(5):950-951.


Abstract



• A single 45-g dose of intravenous ascorbic acid, a metabolic precursor of oxalate, was administered to a patient as adjuvant therapy for primary amyloidosis and the nephrotic syndrome. Acute oliguric renal failure occurred. Postmortem histopathologic examination of renal tissue revealed extensive intratubular deposition of crystalline material, which was confirmed as calcium oxalate by a microincineration technique. There were no extrarenal deposits of calcium oxalate. Plasma oxalate and ascorbic acid concentrations were increased. We conclude that therapy with high-dose ascorbic acid is a potential cause of oxalate nephropathy.

(Arch Intern Med 1985;145:950-951)



Author Affiliations



From the Regional Kidney Disease Program (Drs Lawton, Smith, and Abraham) and the Department of Pathology (Drs Conway and Crosson), Hennepin County Medical Center, Minneapolis.


Footnotes



Accepted for publication Sept 10, 1984.

Reprint requests to Regional Kidney Disease Program, Hennepin County Medical Center, 701 Park Ave, Minneapolis, MN 55415 (Dr Abraham).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Review of Dietary Supplement-Induced Renal Dysfunction
Gabardi et al.
CJASN 2007;2:757-765.
ABSTRACT | FULL TEXT  

Urinary Oxalate Excretion Increases in Home Parenteral Nutrition Patients on a Higher Intravenous Ascorbic Acid Dose
de la Vega et al.
JPEN J Parenter Enteral Nutr 2004;28:435-438.
ABSTRACT | FULL TEXT  

Acute Renal Failure, Oxalosis, and Vitamin C Supplementation : A Case Report and Review of the Literature
Mashour et al.
Chest 2000;118:561-563.
ABSTRACT | FULL TEXT  

Renal Failure Caused by Chemicals, Foods, Plants, Animal Venoms, and Misuse of Drugs: An Overview
Abuelo
Arch Intern Med 1990;150:505-510.
ABSTRACT  

Retinal Oxalosis: A Clinicopathologic Report
Wells et al.
Arch Ophthalmol 1989;107:1638-1643.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.